Latest News
Educational Areas
- mRCC Tool Danish Version
Webinars & Events
Digital Patient Support
Order Support Materials
Login

Search

Home
Optimal treatment for patients in favorable IMDCs risk groups

Back to overview

May 14, 2026

1 minute

Optimal treatment for patients in favorable IMDCs risk groups

Speakers: Katriina Jalkanen & DR Daniel Heinrich
Date: 30th November 2023

Relevant Content

May 20, 2026

Subsequent Treatment Strategies in RCC:How Relapse Timing Guides Clinical Decisions

Webinars & Events
Time: 1 minute

May 20, 2026

Optimizing Duration of Immuno-Therapyin Metastatic Renal Cell Carcinoma– When to Treat, Paus or Stop

Webinars & Events
Time: 1 minute

May 20, 2026

Overview of Nordic Clinical Trials

Webinars & Events
Time: 1 minute

This site is intended for HCPs only. It is produced by Ipsen International team, not intended to specific countries and not intended to US audience. The views expressed by speakers participating in the ON webinars are those of the speakers and not, necessarily, of Ipsen.

Terms & Conditions
Privacy Policy
Cookie Policy
Report Adverse Events

This website is provided by Ipsen: IPSEN AB, Färögatan 33, SE- 164 51 Kista, Sweden. | www.ipsen.com/nordics